Ironwood Pharmaceuticals (IRWD) Gross Margin (2013 - 2020)
Ironwood Pharmaceuticals (IRWD) reported Gross Margin of 99.23% for Q4 2020, up 795.0% on a YoY basis from 11.09% in Q1 2020, and down 0.77% sequentially from 100.0% in Q3 2020.
Ironwood Pharmaceuticals (IRWD) Gross Margin (2013 - 2020) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 7 years of Gross Margin data on file, last reported at 99.23% in Q4 2020.
- For the quarter ending Q4 2020, Gross Margin rose 795.0% year-over-year to 99.23%; the trailing twelve-month figure through Dec 2020 stood at 99.19% (up 477.0% YoY), and the FY2020 full-year result was 99.19%, up 477.0% from the prior year.
- Gross Margin fell to 99.23% in Q4 2020, from 100.0% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q2 2020 to a low of 10631.5% in Q4 2018.
- A 4-year average of 575.25% and a median of 95.61% in 2018 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin plunged 1072196 bps in 2018 and soared 1072278 bps in 2019, its largest moves.
- Tracing IRWD's Gross Margin over 4 years: stood at 90.46% in 2017, then plunged by 11852 bps to 10631.5% in 2018, then jumped by 101 bps to 91.28% in 2019, then increased by 9 bps to 99.23% in 2020.
- Business Quant data shows IRWD's Gross Margin at 99.23% in Q4 2020, 100.0% in Q3 2020, and 100.0% in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Ironwood Pharmaceuticals | 619.48 Mn | 399.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 99.23% |
| Sep 30, 2020 | 100.00% |
| Jun 30, 2020 | 100.00% |
| Mar 31, 2020 | 97.20% |
| Dec 31, 2019 | 91.28% |
| Sep 30, 2019 | 99.61% |
| Jun 30, 2019 | 88.93% |
| Mar 31, 2019 | 98.48% |
| Dec 31, 2018 | -10,631.50% |
| Sep 30, 2018 | 84.46% |
| Jun 30, 2018 | 94.99% |
| Mar 31, 2018 | 96.23% |
| Dec 31, 2017 | 90.46% |
| Sep 30, 2017 | 93.00% |
| Jun 30, 2017 | 94.62% |
| Mar 31, 2017 | 98.98% |
| Sep 30, 2015 | 99.99% |
| Jun 30, 2015 | 70.62% |
| Mar 31, 2015 | 99.96% |
| Dec 31, 2014 | 95.42% |